- This Week at FDA: FDA staff raise concerns about peptide conflicts, top Democrat wants DOGE investigation, and more<p>Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug and medical device regulation, and what we’re reading from around the web. This…raps · 9d ago↗ source
- Mirador unveils part of pipeline with drug from Kira to rival TavneosMirador Therapeutics, the secretive immune disease biotech with more than $650 million in VC funding, is finally revealing a piece of its pipeline. The San Diego biotech said Thursday it reached…Endpoints · 9d ago↗ source
- STAT+: Fresh turmoil roils American Diabetes Association following controversy at conferenceTurmoil at the ADA has taken a fresh turn, with leaders blocking editors at its flagship journal from publishing pieces detailing a controversy at the group’s annual meeting.